Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that women are much more aware of knowledgeable about the obesity drugs GLP-1 ...

Intimation for entering into a Joint Memo of Compromise with DBS Bank India Limited under Regulation 30 of SEBI Listing Regulations. Mar 29, 2025 15:33 Source: BSE Intimation Of Letter(S)/Emails ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

Jai Corp, Orchid Pharma and Schneider Electric Infrastructure were among the 78 stocks that hit their 52-week lows in intraday trade on the BSE. According to Rupak De, Senior Technical Analyst at ...

Donald Trump’s tariff war continues. As his “explosive” import duties on countries, including the whopping 104 per cent on China, come into effect, he has spoken of imposing tariffs on pharmaceuticals ...

Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...

The United States is India’s biggest market for pharmaceutical exports, which are its most successful industrial exports. By Alex Travelli Reporting from New Delhi An important segment of India ...

7. 54 stocks hit 52-week lows in a positive market Some 54 stocks, including Jai Corp, Orchid Pharma and LG Balakrishnan & Bros, hit their 52-week lows in intraday trade on the BSE. Shares of ...

Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics Evaluation and Research, was linked to his advocacy for vaccines ...